Acteon
dental and medical devices
CAPZA has been supporting the external growth strategy of ACTEON through a flexible and reactive private debt offering.
Unitranche
2016, 2018
France
In portfolio
ACTEON creates, develops and distributes high-tech dental and medical devices that enable dentists and surgeons to implement less invasive, safer and quicker operating protocols that are less traumatic for their patients. Based in Merignac near Bordeaux, the group employs almost 750 people and is represented in over 100 countries worldwide.
ACTEON, a leader in high frequency ultrasonics and digital medical imaging, is split into 4 business units: dental equipment, medical equipment, imaging and pharma. Boasting significant technical know-how, ACTEON ’s products are renowned by practitioners for their quality, reliability and innovation. ACTEON employs highly trained technical and sales teams and has set up a powerful distribution network worldwide.
Context & Ambition
In 2016, the Group was looking for a partner to finance a new LBO as well as potential acquisitions as Bridgepoint took over the group alongside the management team. The group wanted to speed up its development by expanding the sales team, broadening the product range and extending its geographic footprint through external growth. In 2018, Bridgepoint sold its equity stake to Dentressangle.
Our Role
In 2016, CAPZA arranged the initial debt financing when Bridgepoint acquired the group alongside the management team.
The unitranche facility also included an acquisition facility, which was drawn in 2017, as Acteon acquired Prodont Holliger, an expert in dental manual instruments. In 2018, we financed Dentressangle’s acquisition and the subsequent development strategy. The group aims to enter the top 5 worldwide for dental imaging and strives to equip 33% of dental practices with ultrasonic surgical devices.
-
21Jun’ 2022CAPZA acquires a stake in NutravaliaCAPZA acquires a significant stake in Nutravalia, a French laboratory specialising in food supplements and parapharmacy products.Read more -
14Jun’ 2022Record-breaking fundraising of nearly €600 million for ArtemidCAPZA announces the successful closing of the Artemid Senior Loan III (ASL III) private debt fundRead more -
1Jun’ 2022A successful first closing for CAPZA 6 Private DebtCAPZA successfully raises ca. €1.2bn in the first closing of its unitranche fund, CAPZA 6 Private DebtRead more
-
12Apr’ 2022CAPZA Transition supports Tevah SystèmesCAPZA acquires a stake in Tevah Systèmes, an independent distributor of security systems.Read more